Bifunctional Oxaliplatin (IV) Prodrug Based pH-Sensitive PEGylated Liposomes for Synergistic Anticancer Action Against Triple Negative Breast cancer

L Bhute, S Dighe, O Katari, V Yadav, S Jain - AAPS PharmSciTech, 2025 - Springer
Triple negative breast cancer (TNBC) exhibits higher susceptibility towards oxaliplatin (OXA)
due to a faulty DNA damage repair system. However, the unfavorable physicochemical …